MX2021015557A - Composición para prevenir, tratar o mejorar enfermedades gastrointestinales que comprende una cepa del género corynebacterium y cultivo de la misma. - Google Patents

Composición para prevenir, tratar o mejorar enfermedades gastrointestinales que comprende una cepa del género corynebacterium y cultivo de la misma.

Info

Publication number
MX2021015557A
MX2021015557A MX2021015557A MX2021015557A MX2021015557A MX 2021015557 A MX2021015557 A MX 2021015557A MX 2021015557 A MX2021015557 A MX 2021015557A MX 2021015557 A MX2021015557 A MX 2021015557A MX 2021015557 A MX2021015557 A MX 2021015557A
Authority
MX
Mexico
Prior art keywords
composition
preventing
gastrointestinal diseases
culture
strain
Prior art date
Application number
MX2021015557A
Other languages
English (en)
Inventor
Yang-Su Kim
Nahum Lee
Young Gi Hong
Original Assignee
Cj Cheiljedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Cheiljedang Corp filed Critical Cj Cheiljedang Corp
Publication of MX2021015557A publication Critical patent/MX2021015557A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente solicitud se refiere a una composición para prevenir, mejorar o tratar enfermedades gastrointestinales que comprende una cepa del género Corynebacterium, un cultivo de la misma y treonina. Dado que se confirma que la composición según la presente solicitud tiene eficacia anti-Helicobacter pylori en experimentos con células, eficacia en mejorar enfermedades gastrointestinales en experimentos con animales y eficacia en la síntesis de moco gástrico excelentes, la composición puede aplicarse como una composición farmacéutica para prevenir o tratar enfermedades gastrointestinales, como alimento para prevenir o mejorar úlceras gástricas o como una composición para pienso.
MX2021015557A 2019-06-14 2020-06-02 Composición para prevenir, tratar o mejorar enfermedades gastrointestinales que comprende una cepa del género corynebacterium y cultivo de la misma. MX2021015557A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20190071007 2019-06-14
PCT/KR2020/007169 WO2020251208A1 (ko) 2019-06-14 2020-06-02 코리네박테리움 속 균주 및 이의 배양물을 포함하는 위장질환 예방, 치료 또는 개선용 조성물

Publications (1)

Publication Number Publication Date
MX2021015557A true MX2021015557A (es) 2022-05-30

Family

ID=73781093

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021015557A MX2021015557A (es) 2019-06-14 2020-06-02 Composición para prevenir, tratar o mejorar enfermedades gastrointestinales que comprende una cepa del género corynebacterium y cultivo de la misma.

Country Status (14)

Country Link
US (1) US20220378854A1 (es)
EP (1) EP3984373A4 (es)
JP (1) JP7293406B2 (es)
KR (1) KR102389326B1 (es)
CN (1) CN114007440B (es)
AU (1) AU2020292062B2 (es)
BR (1) BR112021025133A2 (es)
CA (1) CA3143318C (es)
CO (1) CO2022000125A2 (es)
MX (1) MX2021015557A (es)
PE (1) PE20220018A1 (es)
TW (1) TWI761849B (es)
WO (1) WO2020251208A1 (es)
ZA (1) ZA202200329B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102672024B1 (ko) 2021-10-20 2024-06-05 동국대학교 와이즈캠퍼스 산학협력단 두룸아마이드 a의 제조 방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4719087U (es) * 1971-04-05 1972-11-02
DE69014030T3 (de) * 1989-09-05 1999-06-24 Ajinomoto Kk Mittel für die Verhütung und Behandlung von Diarrhöe.
US7824706B2 (en) * 2003-05-09 2010-11-02 Freedom Health, Llc Dietary supplement and method for the treatment of digestive tract ulcers in equines
BRPI0410861A (pt) 2003-05-30 2006-05-23 Microbia Inc métodos e composições para a produção de aminoácidos
ZA200510463B (en) * 2003-05-30 2007-03-28 Microbia Inc Methods and compositions for amino acid production
JP2007195543A (ja) 2005-12-28 2007-08-09 Ajinomoto Co Inc 乾燥微生物菌体の製造方法
CN104825433A (zh) * 2007-07-03 2015-08-12 达努塔·克鲁谢夫斯卡 α-酮戊二酸的新医药用途
KR100966324B1 (ko) * 2008-01-08 2010-06-28 씨제이제일제당 (주) 향상된 ｌ－쓰레오닌 생산능을 갖는 대장균 및 이를 이용한ｌ－쓰레오닌의 생산 방법
DE102009030342A1 (de) * 2009-06-25 2010-12-30 Evonik Degussa Gmbh Verfahren zur fermentativen Herstellung von organisch chemischen Verbindungen
CN103153298B (zh) 2010-09-24 2015-11-25 佛罗里达大学研究基金会有限公司 用于改善胃肠功能的材料和方法
CN102743754B (zh) * 2011-04-21 2013-11-20 熊慧 一种食道胃肠粘膜保护胶制剂及其应用
KR101335853B1 (ko) * 2011-12-01 2013-12-02 씨제이제일제당 (주) Ｌ-아미노산 및 리보플라빈을 동시에 생산하는 미생물 및 이를 이용한 ｌ-아미노산 및 리보플라빈을 생산하는 방법
JP5938219B2 (ja) 2012-01-23 2016-06-22 株式会社明治 胃排出遅延のための食品用の剤または医療用の剤
RU2014149267A (ru) * 2012-05-09 2016-06-27 Эвоник Индастриз Аг Содержащая l-аминокислоту кормовая добавка в виде гранулята на основе ферментационного бульона и способ ее изготовления
US10076549B2 (en) 2012-11-28 2018-09-18 Smartpak Equine Llc Gastric health supplement and methods thereof
KR20160094485A (ko) * 2015-01-30 2016-08-10 고려대학교 산학협력단 마이얄 반응 생성물을 유효성분으로 포함하는 장기능 개선 또는 항염증용 조성물
CN104824363A (zh) * 2015-05-28 2015-08-12 河南双成生物科技有限公司 一种富含苏氨酸的高蛋白饲料生产方法
KR101947945B1 (ko) * 2018-01-25 2019-02-13 씨제이제일제당 (주) L-아미노산을 생산하는 코리네박테리움 속 미생물 및 이를 이용한 l-아미노산의 생산방법

Also Published As

Publication number Publication date
JP2022537968A (ja) 2022-08-31
US20220378854A1 (en) 2022-12-01
EP3984373A4 (en) 2023-07-12
AU2020292062B2 (en) 2024-01-18
KR102389326B1 (ko) 2022-04-21
CA3143318C (en) 2024-06-18
AU2020292062A1 (en) 2022-02-03
CN114007440A (zh) 2022-02-01
WO2020251208A1 (ko) 2020-12-17
TW202106171A (zh) 2021-02-16
ZA202200329B (en) 2023-11-29
JP7293406B2 (ja) 2023-06-19
PE20220018A1 (es) 2022-01-11
EP3984373A1 (en) 2022-04-20
TWI761849B (zh) 2022-04-21
BR112021025133A2 (pt) 2022-03-15
CN114007440B (zh) 2024-04-16
CO2022000125A2 (es) 2022-01-28
CA3143318A1 (en) 2020-12-17
KR20200143262A (ko) 2020-12-23

Similar Documents

Publication Publication Date Title
HRP20191344T1 (hr) Sastavi koji sadrže bakterijske sojeve
BRPI0515227A (pt) cepa de lactobacillus rhamnosus, composição para produzir cla, processo para produção em massa de cla, alimento funcional com redução de corpo de gordura, produtos diários, alimentos fermentados e medicamento para prevenção e para tratamento de doenças relacionadas á obesidade
CN111601610A8 (zh) 使用布劳特氏菌属菌株治疗疾病的组合物和方法
EA201800564A1 (ru) Штамм akkermansia glycaniphilus, композиция, содержащая штамм, применение штамма и композиции, способ повышения уровня штамма akkermansia glycaniphilus в желудочно-кишечном тракте
MX2021009285A (es) Anticuerpos novedosos de unión a la proteína de antígenos de diferenciación 40 (cd40).
BRPI0515618A (pt) cepa de lactobacillus plantarum, composição para produzir cla, processo para produção em massa de cla alimento funcional redutor de corpos de gordura, produtos diários, alimentos fermentados, medicamento para prevenção e tratamento de doenças relacionadas com a obesidade
NZ603901A (en) Vectors and sequences for the treatment of diseases
MX2009012694A (es) Composicones y metodos utiles para modular la inmunidad, mejorar la eficacia de vacunas, disminuir la morbilidad asociada con infecciones cronicas por fhv-1, y prevenir o tratar la conjuntivitis.
ZA202200329B (en) Composition for preventing, treating, or improving gastrointestinal diseases comprising strain of genus corynebacterium and culture thereof
AR084892A1 (es) Composicion de aditivo para pienso
WO2017139697A8 (en) Bacteria engineered to treat diseases associated with hyperammonemia
MX2021000388A (es) Suplemento alimenticio.
MX2018006905A (es) Bifidobacterium longum para el tratamiento de la obesidad y trastornos metabolcos asociados.
BR112016024860A2 (pt) composição para uso no tratamento ou prevenção de infecções virais ou bacterianas em um sujeito que passa por quimioterapia antitumor, tratamento de leucemia ou terapia contra aids compreendendo l. reuteri ler03 e/ou l. salivarius l206
MX2021007908A (es) Suplementos alimenticios.
CR20220656A (es) Unión de anticuerpos multiespecíficos a bcma
MX2022006407A (es) Composiciones bacterianas diseñadas y usos de estas.
WO2014033574A3 (en) Protein stabilized probiotics and personal care products
MX2023000840A (es) Combinacion de cepas de lactobacillus y uso de las mismas en salud animal.
MX2017003217A (es) Tratamiento del cancer con el inhibidor de la alfa-amilasa en los animales de compañía.
MX2022002245A (es) Compuesto y metodos para tratar enfermedades relacionadas con oxalato.
WO2020231031A3 (ko) 락토바실러스 아시도필루스를 포함하는 갱년기 여성의 근관절통, 두통, 또는 질 건조증의 예방, 개선, 또는 치료용 조성물
WO2023019198A3 (en) Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof
WO2020109233A3 (en) Trmt2a inhibitors for use in the treatment of polyglutamine diseases
WO2019054641A3 (ko) 락토바실러스 플란타룸을 포함하는 위장관 질환의 예방 및 개선용 조성물